April 29, 2020 / 8:05 PM / a month ago

BRIEF-Biomarin Reports Q1 2020 Total Revenue Growth Of 25% To $502 Mln

April 29 (Reuters) - Biomarin Pharmaceutical Inc:

* BIOMARIN ANNOUNCES FIRST QUARTER 2020 TOTAL REVENUE GROWTH OF 25% TO $502 MILLION

* Q1 REVENUE $502.1 MILLION VERSUS REFINITIV IBES ESTIMATE OF $468.8 MILLION

* FOR FULL-YEAR 2020 BIOMARIN CONTINUES TO EXPECT TO BE PROFITABLE ON A GAAP BASIS FOR FIRST TIME

* 2020 FULL-YEAR TOTAL REVENUE GUIDANCE REDUCED BY 5%

* QTRLY EARNINGS PER SHARE $0.44

* EXPECT MINOR FINANCIAL IMPACT IN NEAR-TERM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below